Health care providers underestimate symptom intensities of cancer patients: a multicenter European study

Eivor A Laugsand, Mirjam A G Sprangers, Kristin Bjordal, Frank Skorpen, Stein Kaasa, Pål Klepstad, Eivor A Laugsand, Mirjam A G Sprangers, Kristin Bjordal, Frank Skorpen, Stein Kaasa, Pål Klepstad

Abstract

Background: Many patients with advanced cancer depend upon health care providers for symptom assessment. The extent of agreement between patient and provider symptom assessments and the association of agreement with demographic- and disease-related factors was examined.

Methods: This cross-sectional study included 1933 patient-health care provider dyads, from 11 European countries. Patients reported symptoms by using the four-point scales of the European Organization of Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) version 3, and providers used corresponding four-point categorical scales. Level of agreement was addressed at the group level (Wilcoxon Signed-Rank test), by difference scores (provider score minus patient score), at the individual level (Intraclass Correlation Coefficients, ICCs) and visually by Bland-Altman plots. Absolute numbers and chi-square tests were used to investigate the relationship between agreement and demographic-, as well as disease-related factors.

Results: The prevalence of symptoms assessed as moderate or severe by patients and providers, respectively, were for pain (67 vs.47%), fatigue (71 vs. 54%), generalized weakness (65 vs. 47%), anorexia (47 vs. 25%), depression (31 vs. 17%), constipation (45 vs. 30%), poor sleep (32 vs. 21%), dyspnea (30 vs. 16%), nausea (27 vs. 14%), vomiting (14 vs. 6%) and diarrhea (14 vs. 6%). Symptom scores were identical or differed by only one response category in the majority of patient-provider assessment pairs (79-93%). Providers underestimated the symptom in approximately one of ten patients and overestimated in 1% of patients. Agreement at the individual level was moderate (ICC 0.38 to 0.59). Patients with low Karnofsky Performance Status, high Mini Mental State-score, hospitalized, recently diagnosed or undergoing opioid titration were at increased risk of symptom underestimation by providers (all p < 0.001). Also, the agreement was significantly associated with drug abuse (p = 0.024), provider profession (p < 0.001), cancer diagnosis (p < 0.001) and country (p < 0.001).

Conclusions: Considerable numbers of health care providers underestimated symptom intensities. Clinicians in cancer care should be aware of the factors characterizing patients at risk of symptom underestimation.

Figures

Figure 1
Figure 1
Bland-Altman plots, one for each symptom (see also Figure 2). The difference between patient and provider score (difference score = health care provider score minus patient score) plotted against mean symptom score. The size of markers reflect the number of individual observations and only the line of equality (difference = 0) is shown. Negative differences mean that providers underestimated the symptom. The larger the size of the markers at one side of the line of equality, the larger was the tendency of a systematic difference between assessments (i.e. more observations below the line suggest that providers had a negative bias and underestimated symptom intensity). Whether differences between provider and patient assessments changes with the mean value of symptom intensity is determined by looking for patterns along the x-axis. (A): Pain. (B): Fatigue. (C): Constipation. (D): Vomiting.
Figure 2
Figure 2
Bland-Altman plots, one for each symptom (see also Figure 1). The difference between patient and provider score (difference score = health care provider score minus patient score) plotted against mean symptom score. The size of markers reflect the number of individual observations and only the line of equality (difference = 0) is shown. Negative differences mean that providers underestimated the symptom. The larger the size of the markers at one side of the line of equality, the larger was the tendency of a systematic difference between assessments (i.e. more observations below the line suggest that providers had a negative bias and underestimated symptom intensity). Whether differences between provider and patient assessments changes with the mean value of symptom intensity is determined by looking for patterns along the x-axis. (A): Generalized weakness. (B): Anorexia. (C): Depression. (D): Poor sleep. (E): Dyspnea. (F): Nausea. (G): Diarrhea.

References

    1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581–592. doi: 10.1093/annonc/mdl498.
    1. Martin-Moreno JM, Harris M, Gorgojo L, Clark D, Normand C, Centeno C. European Parliament, eds. Policy Department, Economic and Scientific Policy. European Parliament's Committee on the Environment, Public Health and Food Safety; 2008. Palliative care in the European Union.
    1. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ. Pain and Its Treatment in Outpatients with Metastatic Cancer. N Engl J Med. 1994;330:592–596. doi: 10.1056/NEJM199403033300902.
    1. Nekolaichuk CL, Bruera E, Spachynski K, MacEachern T, Hanson J, Maguire TO. A comparison of patient and proxy symptom assessments in advanced cancer patients. Palliat Med. 1999;13:311–323. doi: 10.1191/026921699675854885.
    1. Kaasa S, Loge JH, Fayers P, Caraceni A, Strasser F, Hjermstad MJ, Higginson I, Radbruch L, Haugen DF. Symptom assessment in palliative care: A need for international collaboration. J Clin Oncol. 2008;26:3867–3873. doi: 10.1200/JCO.2007.15.8881.
    1. Kirkova J, Davis MP, Walsh D, Tiernan E, O'Leary N, LeGrand SB, Lagman RL, Russell KM. Cancer symptom assessment instruments: a systematic review. J Clin Oncol. 2006;24:1459–1473. doi: 10.1200/JCO.2005.02.8332.
    1. Nekolaichuk CL, Maguire TO, Suarez-Almazor M, Rogers WT, Bruera E. Assessing the reliability of patient, nurse, and family caregiver symptom ratings in hospitalized advanced cancer patients. J Clin Oncol. 1999;17:3621–3630.
    1. Hearn J, Higginson IJ. Outcome measures in palliative care for advanced cancer patients: a review. J Public Health Med. 1997;19:193–199.
    1. Oldenmenger WH, Smitt PAES, van Dooren S, Stoter G, van der Rijt CCD. A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: A critical appraisal. Eur J Cancer. 2009;45:1370–1380. doi: 10.1016/j.ejca.2009.01.007.
    1. Vonroenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician Attitudes and Practice in Cancer Pain Management - a Survey from the Eastern-Cooperative-Oncology-Group. Ann Intern Med. 1993;119:121–126.
    1. Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol. 1998;51:617–631. doi: 10.1016/S0895-4356(98)00040-7.
    1. Portenoy RK, Lesage P. Management of cancer pain. Lancet. 1999;353:1695–1700. doi: 10.1016/S0140-6736(99)01310-0.
    1. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 1997;79:835–842. doi: 10.1002/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>;2-#.
    1. Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol. 1992;45:743–760. doi: 10.1016/0895-4356(92)90052-O.
    1. Sneeuw KCA, Sprangers MAG, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol. 2002;55:1130–1143. doi: 10.1016/S0895-4356(02)00479-1.
    1. McPherson CJ, Addington-Hall JM. Judging the quality of care at the end of life: can proxies provide reliable information? Soc Sci Med. 2003;56:95–109. doi: 10.1016/S0277-9536(02)00011-4.
    1. Broberger E, Tishelman C, von Essen L. Discrepancies and similarities in how patients with lung cancer and their professional and family caregivers assess symptom occurrence and symptom distress. J Pain Symptom Manag. 2005;29:572–583. doi: 10.1016/j.jpainsymman.2004.11.006.
    1. Brunelli C, Costantini M, Di Giulio P, Gallucci M, Fusco F, Miccinesi G, Paci E, Peruselli C, Morino P, Piazza M. et al.Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symptom Manag. 1998;15:151–158. doi: 10.1016/S0885-3924(97)00351-5.
    1. Ewing G, Rogers M, Barclay S, McCabe J, Martin A, Campbell M, Todd C. Palliative care in primary care: a study to determine whether patients and professionals agree on symptoms. Br J Gen Pract. 2006;56:27–34.
    1. Grossman SA, Sheidler VR, Swedeen K, Mucenski J, Piantadosi S. Correlation of Patient and Caregiver Ratings of Cancer Pain. J Pain Symptom Manag. 1991;6:53–57. doi: 10.1016/0885-3924(91)90518-9.
    1. Horton R. Differences in assessment of symptoms and quality of life between patients with advanced cancer and their specialist palliative care nurses in a home care setting. Palliat Med. 2002;16:488–494. doi: 10.1191/0269216302pm588oa.
    1. Kutner JS, Bryant LL, Beaty BL, Fairclough DL. Symptom distress and quality-of-life assessment at the end of life: the role of proxy response. J Pain Symptom Manag. 2006;32:300–310. doi: 10.1016/j.jpainsymman.2006.05.009.
    1. Oi-Ling K, Man-Wah DT, Kam-Hung DN. Symptom distress as rated by advanced cancer patients, caregivers and physicians in the last week of life. Palliat Med. 2005;19:228–233. doi: 10.1191/0269216305pm1001oa.
    1. Petersen MA, Larsen H, Pedersen L, Sonne N, Groenvold M. Assessing health-related quality of life in palliative care: Comparing patient and physician assessments. Eur J Cancer. 2006;42:1159–1166. doi: 10.1016/j.ejca.2006.01.032.
    1. Presant CA. Quality of Life in Cancer-Patients - Who Measures What. Am J Clin Oncol. 1984;7:571–573. doi: 10.1097/00000421-198410000-00036.
    1. Rhodes VA, McDaniel RW, Matthews CA. Hospice patients' and nurses' perceptions of self-care deficits based on symptom experience. Cancer Nurs. 1998;21:312–319. doi: 10.1097/00002820-199810000-00002.
    1. Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH. Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses. Br J Cancer. 1999;81:87–94. doi: 10.1038/sj.bjc.6690655.
    1. Stephens R, Hopwood P, Girling D, Machin D. Randomized trials with quality of life endpoints: Are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? Qual Life Res. 1997;6:225–236. doi: 10.1023/A:1026458604826.
    1. Zloklikovits S, Andritsch E, Frohlich B, Verebes J, Dietmaier G, Samonigg H. Assessing symptoms of terminally-ill patients by different raters: a prospective study. Palliat Support Care. 2005;3:87–98. doi: 10.1017/S1478951505050169.
    1. Petersen MA, Pedersen L, Groenvold M. Does the agreement of patient and physician assessments of health related quality of life in palliative care depend on patient characteristics? Palliat Med. 2007;21:289–294. doi: 10.1177/0269216307077694.
    1. Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N. The European Organization for Research and Treatment of Cancer QLQ-C30 - A Quality-Of-Life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. doi: 10.1093/jnci/85.5.365.
    1. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6.
    1. Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43:411–431. doi: 10.1016/j.jpsychires.2008.04.014.
    1. Karnofsky D, Abelmann W, Craver L, Burchenal JH. The use of nitrogen mustard in the palliative treatment of cancer. Cancer. 1948;1:634–656. doi: 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>;2-L.
    1. Lee J, Koh D, Ong CN. Statistical Evaluation of Agreement between 2 Methods for Measuring a Quantitative Variable. Comput Biol Med. 1989;19:61–70. doi: 10.1016/0010-4825(89)90036-X.
    1. Landis JR, Koch GG. Measurement of Observer Agreement for Categorical Data. Biometrics. 1977;33:159–174. doi: 10.2307/2529310.
    1. Fleiss JL, Cohen J. Equivalence of Weighted Kappa and Intraclass Correlation Coefficient as Measures of Reliability. Educ Psychol Meas. 1973;33:613–619. doi: 10.1177/001316447303300309.
    1. Lobchuk MM, Degner LF. Symptom experiences: Perceptual accuracy between advanced-stage cancer patients and family caregivers in the home care setting. J Clin Oncol. 2002;20:3495–3507. doi: 10.1200/JCO.2002.01.153.
    1. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310.
    1. von Essen L. Proxy ratings of patient quality of life - Factors related to patient-proxy agreement. Acta Oncol. 2004;43:229–234. doi: 10.1080/02841860410029357.
    1. Simpson M, Buckman R, Stewart M, Maguire P, Lipkin M, Novack D, Till J. Doctor-Patient Communication - the Toronto Consensus Statement. Br Med J. 1991;303:1385–1387. doi: 10.1136/bmj.303.6814.1385.
    1. Laugsand E, Kaasa S, de Conno F, Hanks G, Klepstad P. Intensity and treatment of symptoms in 3,030 palliative care patients: a cross-sectional survey of the EAPC Research Network. J Opioid Manag. 2009;5:11–21.

Source: PubMed

3
Subskrybuj